[1]
N. R. Rijhwani, “A study on Institutional oversight and the effectiveness of clinical trial strategic alliances”, RRIJM, vol. 2, no. 4, pp. 15–21, Dec. 2022, doi: 10.31305/rrijm2022.v02.n04.004.